STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Austrian Science Fund (SFB F4707, SFB-F06105)
This publication has 59 references indexed in Scilit:
- Constitutive activation of JAK2 in mammary epithelium elevates Stat5 signalling, promotes alveologenesis and resistance to cell death, and contributes to tumourigenesisCell Death & Differentiation, 2011
- Growth hormone–STAT5 regulation of growth, hepatocellular carcinoma, and liver metabolismAnnals of the New York Academy of Sciences, 2011
- Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in miceHepatology, 2011
- Abrogation of growth hormone secretion rescues fatty liver in mice with hepatocyte-specific deletion of JAK2Journal of Clinical Investigation, 2011
- The Transcription Factors Signal Transducer and Activator of Transcription 5A (STAT5A) and STAT5B Negatively Regulate Cell Proliferation Through the Activation of Cyclin-Dependent Kinase Inhibitor 2b ( Cdkn2b ) and Cdkn1a ExpressionHepatology, 2010
- p21 in cancer: intricate networks and multiple activitiesNature Reviews Cancer, 2009
- Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-β and STAT3 activationJournal of Experimental Medicine, 2009
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- Hepatocellular carcinoma pathogenesis: from genes to environmentNature Reviews Cancer, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005